Optune plus transducer renewal
Ended Awarded
- Contract number
- 36C26326N0351
- Awardee
-
Novocure Inc. UEI P3S3GK3DTUA8
- Awarding agency
-
Veterans Integrated Service Network 23
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $49,749
Award facts
- Contract value 100% obligated
- $49,748.73 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 334510 Electromedical and Electrotherapeutic Apparatus Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Minneapolis, MN 55417, USA
Award details come from SAM.gov/FPDS.
About this award
The Department of Veterans Affairs, Veterans Integrated Service Network (VISN) 23, awarded a $49,748.73 firm fixed-price delivery order to Novocure Inc. on January 23, 2026, for the renewal of Optune Plus transducers, with an ultimate completion date of April 23, 2026. This delivery order was issued without a set-aside designation and is being performed in Minneapolis, Minnesota. The award is issued under Novocure's existing General Services Administration Federal Supply Schedule contract (FSS-65-II-A) for Medical Equipment and Supplies, a $28.85 million multiple-award vehicle established in November 2022 and extending through October 31, 2027, which streamlines the VA's procurement of specialized oncology equipment and services.
Novocure Inc., a foreign-owned medical device manufacturer specializing in cancer treatment technologies, serves as the sole prime contractor with no subcontractor involvement. The company manufactures the Optune system, a non-invasive medical device utilizing Tumor Treating Fields technology and approved by the FDA for treating solid tumors including glioblastoma and mesothelioma. As the exclusive provider of this proprietary technology to the VA, Novocure has issued over 100 delivery orders across multiple VISNs nationwide, with this transducer renewal delivery order supporting the VA's strategic objective to expand veterans' access to innovative, non-invasive cancer treatment options at VA medical facilities.
Quick answers
Who was awarded contract 36C26326N0351?
36C26326N0351 was awarded to Novocure Inc. by Veterans Integrated Service Network 23 (Veterans Health Administration) on January 23, 2026.
How much is contract 36C26326N0351 worth?
The government has obligated $49,749 on 36C26326N0351.
Is contract 36C26326N0351 an order under another contract?
Yes. 36C26326N0351 is a delivery order under 36F79723D0016, a federal supply schedule, on Medical Equipment and Supplies (FSS-65-II-A).
Was contract 36C26326N0351 competed?
The extent of competition for 36C26326N0351 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award